About STEMBIOSYS INC.
StemBioSys develops CELLvo™ Matrix Plus, a cell-derived matrix substrate that supports the maturation and culture of various cell types, including cardiomyocytes, for research and drug safety testing. The company provides specialized products for predictive, cell-based assays.
Development of CELLvo™ Matrix Plus for cell culture and maturationSupport for cardiomyocyte maturation and drug safety testingCustom coating of cell culture plates and flasksProviding specialized cell products such as human atrial cardiomyocytes and mesenchymal stem cells
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $15K | |
| Federal contract award | Department of Health and Human Services | $67K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to STEMBIOSYS INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.